Clinical Trial Resource Center


Therapeutic Areas: Oncology | Hematology

Hematologic Neoplasms Clinical Trials


A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Scottsdale : Scottsdale Healthcare Research Institute

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

Los Angeles : Children's Hospital Los Angeles

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Maryland

Baltimore : The Sidney Kimmel Comprehensive Cancer Center Updated

A Phase 1 clinical study for patients with Hematologic Neoplasms

Massachusetts

Boston : Dana Farber Cancer Institute Updated

A Phase 1 clinical study for patients with Hematologic Neoplasms

New York

New York : New York Presbyterian Hospital-Weill Cornell Med College Updated

A Phase 1 clinical study for patients with Hematologic Neoplasms

Oregon

Portland : Oregon Health & Science University Updated

A Phase 1 clinical study for patients with Hematologic Neoplasms

South Carolina

Greenville : Greenville Hospital System

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Texas

Houston : Baylor College of Medicine/ Texas Children's Hospital

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston : The University Of Texas Md Anderson Cancer Center Updated

A Phase 1 clinical study for patients with Hematologic Neoplasms

Washington

Seattle : Seattle Cancer Care Alliance Updated

A Phase 1 clinical study for patients with Hematologic Neoplasms

France

Lille : CHRU Lille

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Paris : Hopital Saint Louis

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Germany

Frankfurt : University Hospital Johann Wolfgang Goethe

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Münster : Univercity Clinic Münster

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Israel

Tel Aviv : Updated

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Italy

Rome : IRCCS Ospedale Pediatrico Bambino Gesù

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Torino : Ospedale Molinette

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Japan

Fukuoka : Research site

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Isehara : Research site

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Kashiwa : National Cancer Center Hospital East

A clinical trial seeking patients for a research study of Oral azacitidine

Nagoya-shi : Research site

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Tokyo : National Cancer Center Hospital

A clinical trial seeking patients for a research study of Oral azacitidine

Tokyo : The Cancer Institute Hospital of JFCR

A clinical trial seeking patients for a research study of Oral azacitidine

Poland

Wroclaw : Wroclaw Medical University

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Switzerland

Bellinzona : IOSI

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Stay Informed
Sign up for e-newsletters, major
events and research alerts!

3520 Lake Ave., Ste 202, Wilmette, IL 60091 | Office: 847.424.0600 | Fax: 847.424.0606 | Contact Us